Renal cell carcinoma primary prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{CMG}} {{Renal cell carcinoma}} ==Overview== ==Prevention== Prevention of kidney cancer Although the reasons for the development of kidney cancer are not clear, epidemic d...") |
Farima Kahe (talk | contribs) No edit summary |
||
| (14 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
{{CMG}} | __NOTOC__ | ||
{{CMG}} {{AE}} {{F.K}} | |||
{{Renal cell carcinoma}} | {{Renal cell carcinoma}} | ||
==Overview== | ==Overview== | ||
Primary prevention strategies include early [[screening]], changing lifestyle, decreasing exposure to occupational risk factors, and controlling of [[hypertension]]. | |||
== | ==Primary prevention== | ||
Although the etiology for the development of kidney cancer are not well understood, epidemic data shows the effective measures for the primary prevention of renal cell carcinoma include followings:<ref name="pmid20390283">{{cite journal |vauthors=Weikert S, Ljungberg B |title=Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention |journal=World J Urol |volume=28 |issue=3 |pages=247–52 |date=June 2010 |pmid=20390283 |doi=10.1007/s00345-010-0555-1 |url=}}</ref><ref name="pmid29059103">{{cite journal |vauthors=Tahbaz R, Schmid M, Merseburger AS |title=Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition |journal=Curr Opin Urol |volume=28 |issue=1 |pages=62–79 |date=January 2018 |pmid=29059103 |doi=10.1097/MOU.0000000000000454 |url=}}</ref> | |||
Although the | |||
*Early screening and treating genetic and hereditary diseases | *Early screening and treating genetic and hereditary diseases | ||
*Changing lifestyle | *Changing lifestyle | ||
*Decreasing exposure to | **[[Smoking cessation]] | ||
*Early detection and control of hypertension | **Controlling weight | ||
*Decreasing exposure to occupational risk factors including: | |||
**[[Asbestos]] | |||
**[[Cadmium]] | |||
**[[Benzene]] | |||
**[[Herbicides]] | |||
**Organic solvents particularly [[trichloroethylene]] | |||
*Early detection and control of [[hypertension]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Kidney diseases]] | |||
[[Category:Types of cancer]] | |||
[[Category:Nephrology]] | |||
[[Category:Mature chapter]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Nephrology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 16:30, 11 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
|
Renal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal cell carcinoma primary prevention On the Web |
|
American Roentgen Ray Society Images of Renal cell carcinoma primary prevention |
|
Risk calculators and risk factors for Renal cell carcinoma primary prevention |
Overview
Primary prevention strategies include early screening, changing lifestyle, decreasing exposure to occupational risk factors, and controlling of hypertension.
Primary prevention
Although the etiology for the development of kidney cancer are not well understood, epidemic data shows the effective measures for the primary prevention of renal cell carcinoma include followings:[1][2]
- Early screening and treating genetic and hereditary diseases
- Changing lifestyle
- Smoking cessation
- Controlling weight
- Decreasing exposure to occupational risk factors including:
- Asbestos
- Cadmium
- Benzene
- Herbicides
- Organic solvents particularly trichloroethylene
- Early detection and control of hypertension
References
- ↑ Weikert S, Ljungberg B (June 2010). "Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention". World J Urol. 28 (3): 247–52. doi:10.1007/s00345-010-0555-1. PMID 20390283.
- ↑ Tahbaz R, Schmid M, Merseburger AS (January 2018). "Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition". Curr Opin Urol. 28 (1): 62–79. doi:10.1097/MOU.0000000000000454. PMID 29059103.